These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 14990463)

  • 21. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptors.
    Lanzafame A; Christopoulos A
    J Pharmacol Exp Ther; 2004 Mar; 308(3):830-7. PubMed ID: 14617684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of M1 muscarinic receptors expressed in CHOm1 cells by panaxynol via cAMP pathway.
    Hao W; Xing-Jun W; Yong-Yao C; Liang Z; Yang L; Hong-Zhuan C
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):121-6. PubMed ID: 15936523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel allosteric effects of amiodarone at the muscarinic M5 receptor.
    Stahl E; Ellis J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):214-22. PubMed ID: 20348203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing allosteric peptide ligands targeting a globular protein.
    Selz KA; Samoylova TI; Samoylov AM; Vodyanoy VJ; Mandell AJ
    Biopolymers; 2007 Jan; 85(1):38-59. PubMed ID: 17009317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
    Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
    BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.
    De Lorme KC; Sikorski KL; Grant MK; El-Fakahany EE
    Neurosci Lett; 2006 Dec; 410(1):11-4. PubMed ID: 17052840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42).
    Janíčková H; Rudajev V; Zimčík P; Jakubík J; Tanila H; El-Fakahany EE; Doležal V
    Neuropharmacology; 2013 Apr; 67():272-83. PubMed ID: 23206502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.
    Jakubík J; Tucek S; El-Fakahany EE
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1033-41. PubMed ID: 12023535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
    Bradley KN; Rowan EG; Harvey AL
    Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Throughput Agonist Shift Assay Development for the Analysis of M
    Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD
    SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
    Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
    Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode matches in hydrophobic free energy eigenfunctions predict peptide-protein interactions.
    Mandell AJ; Owens MJ; Selz KA; Morgan WN; Shlesinger MF; Nemeroff CB
    Biopolymers; 1998 Aug; 46(2):89-101. PubMed ID: 9664843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
    Lanzafame AA; Sexton PM; Christopoulos A
    Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.
    Šantrůčková E; Doležal V; El-Fakahany EE; Jakubík J
    PLoS One; 2014; 9(2):e88910. PubMed ID: 24558448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M
    Dallagnol JCC; Khajehali E; van der Westhuizen ET; Jörg M; Valant C; Gonçalves AG; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2018 Apr; 61(7):2875-2894. PubMed ID: 29544056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states.
    Fruchart-Gaillard C; Mourier G; Marquer C; Stura E; Birdsall NJ; Servent D
    Mol Pharmacol; 2008 Dec; 74(6):1554-63. PubMed ID: 18784346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpreting the structural mechanism of action for MT7 and human muscarinic acetylcholine receptor 1 complex by modeling protein-protein interaction.
    Xu J; Xu J; Chen H
    J Biomol Struct Dyn; 2012; 30(1):30-44. PubMed ID: 22571431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.